Company Filing History:
Years Active: 2018
Title: Isabelle Lehoux: Innovator in CaMKII Inhibitors
Introduction
Isabelle Lehoux is a prominent inventor based in Millbrae, CA (US). She has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit Ca/calmodulin-dependent protein kinase (CaMKII). Her work has the potential to impact various therapeutic applications.
Latest Patents
Isabelle holds a patent for her invention titled "CaMKII inhibitors and uses thereof." This patent provides compounds that are useful as inhibitors of CaMKII, along with compositions and methods for their use. This innovation represents a crucial advancement in the understanding and manipulation of protein kinases.
Career Highlights
Isabelle is currently employed at Allosteros Therapeutics, Inc., where she continues to explore and develop innovative solutions in the realm of protein kinase inhibition. Her expertise and dedication to research have positioned her as a valuable asset in her field.
Collaborations
Isabelle has collaborated with notable colleagues, including Daniel Emil Levy and Howard Schulman. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic strategies.
Conclusion
Isabelle Lehoux's contributions to the field of biochemistry, particularly through her patent on CaMKII inhibitors, highlight her role as an innovative inventor. Her work at Allosteros Therapeutics, Inc. and collaborations with esteemed colleagues further underscore her impact on advancing therapeutic research.